LRRK2 and Parkinson disease: Those who are potentially at risk for PD (e.g., leucine-rich repeat kinase 2 (LRRK2) carriers, those with rapid eye movement sleep behavior disorder, anosmia, constipation, abnormal positron emission tomography (PET) scans, etc.)may be excellent candidates for primary prevention.